Fundz

Tessellate Bio Appoints Dr. Katie Chapman as Chief Scientific Officer

PRIVATEOct 01, 2025

Position

Chief Scientific Officer

Company

Tessellate Bio

Katie Chapman
katie.chapman@tessellatebio.com
AmsterdamBiotechnologyHealth Careresearch

Description

Tessellate Bio has announced the appointment of Dr. Katie Chapman as Chief Scientific Officer. She succeeds Dr Jürgen Moll, who transitions into a Consultant role.

Quick answer

Tessellate Bio Appoints Dr. Katie Chapman as Chief Scientific Officer (October 1, 2025). Tessellate Bio is based in Amsterdam, North Holland, Netherlands.

Who is the new Chief Scientific Officer at Tessellate Bio?
Tessellate Bio named Katie Chapman Chief Scientific Officer, announced October 1, 2025.
What did Tessellate Bio announce on October 1, 2025?
Tessellate Bio has announced the appointment of Dr. Katie Chapman as Chief Scientific Officer. She succeeds Dr Jürgen Moll, who transitions into a Consultant role.
What does Tessellate Bio do?
Tessellate BIO discovers and develops novel precision oncology medicines with the mission to turn cancer patients into cancer survivors.
Where is Tessellate Bio based?
Tessellate Bio is based in Amsterdam, North Holland, Netherlands.
Which similar companies made leadership changes around the same time?
Inventiva (October 1, 2025), Symeres (October 1, 2025), Climb Bio, Inc. (October 1, 2025) and Quotient Therapeutics (October 2, 2025) also announced leadership changes within 45 days of Tessellate Bio.

Source: Fundz verified event record.

Other recent leadership changes in research and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Tessellate Bio, and when

A new leader at Tessellate Bio brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Tessellate Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Tessellate Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Tessellate Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Tessellate Bio

Location

Amsterdam, North Holland, Netherlands

About

Tessellate BIO discovers and develops novel precision oncology medicines with the mission to turn cancer patients into cancer survivors. A private preclinical stage biotechnology company, Tessellate BIO is redefining Synthetic Lethality by developing drugs that target unexplored or difficult to drug pathways beyond HRD.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Tessellate Bio changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Andree
Senior decision-maker at this company
••••••••@••••••••

See Andree's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Tessellate Bio's next move

Learn about Strategic plan

Tessellate Bio changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.